Gustave Roussy

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Gustave Roussy
Sep 12, 2024, 09:59 | Insight
Doxorubicin–Trabectedin with Trabectedin maintenance in Leiomyosarcoma
Vivek Subbiah shared a post on X about a recent paper by Patricia Pautier et al., commenting: “Doxorubicin–Trabectedin…
Aug 22, 2024, 15:06 | Insight
Elias Karam: The ultimate dilemma of corticosteroids and Immunotherapy
Elias Karam, Hematology and Medical Oncology Fellow at Gustave Roussy, shared a post on LinkedIn about…
Aug 19, 2024, 09:57 | Insight
3rd line treatments in pancreatic cancer
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X about a…
Aug 11, 2024, 11:56 | Blog
Florian Scotté: Mascc and Gustave Roussy support Lety and Olivier around the world
Florian Scotté, Head of the Interdisciplinary Patient Pathway Organization Department (DIOPP) at Gustave Roussy, posted on…
Aug 9, 2024, 18:04 | Insight
Meyer May-Lucie: New publication in The Lancet reviewing the treatment of advanced lung cancer
Meyer May-Lucie, Doctor at Gustave Roussy, shared on X about a recent paper titled "New…
Jul 13, 2024, 12:22 | Insight
Key Highlights from KCRS24 by Sumanta K. Pal
Kidney Cancer Research Summit or the KCRS24 was a conference held on 11th-12th July in Boston focused…
Jul 13, 2024, 11:17 | Blog
David Planchard: New option in the 1st line strategy for NSCLC EGFRmut patients
David Planchard, Thoracic Oncologist at Gustave Roussy, shared on LinkedIn: "Great news, a new option…
Jul 3, 2024, 17:29 | Blog
Benjamin Besse: Stop pembro after 2 years?
Benjamin Besse, Head of Clinical Research at Gustave Roussy, shared on X: "Stop pembro after…
Jul 3, 2024, 10:28 | Societies
Florian Scotté: Thanks to our partners for the 2024 MASCC-AFSOS-ISOO meeting
Florian Scotté, Head of the Interdisciplinary Patient Pathway Organization Department (DIOPP) at Gustave Roussy, posted on…
Jul 2, 2024, 13:38 | Insight
Yan Pei-Ming gives a face to the Institute with a monumental portrait of Professor Gustave Roussy
Gustave Roussy shared a post on LinkedIn:                ,…
Jun 30, 2024, 12:02 | Blog
Improving quality of life after breast cancer treatment
Gary L. Thompson, Board Chair of Side-Out Foundation, shared on X: "Day 199/262 of my 'tour'…
Jun 30, 2024, 08:07 | Societies
9 Posts You Should Not Miss From Day 3 of ESMOGI24!
ESMOGI24 is taking place as an onsite event in Munich, Germany, from 26 to 29 June 2024,…
Jun 29, 2024, 13:12 | Societies
Poster on early-onset CCA won Best Poster at ESMOGI24
Natalia Tissera, PhD Student at Vall d'Hebron Institute of Oncology (VHIO), shared on X: "Thrilled…
Jun 29, 2024, 06:20 | Societies
Gustave Roussy received the renewal of the MASCC Center of Excellence Certification
Florian Scotté, Head of the Interdisciplinary Department for Organization of Patient Pathways (DIOPP) at Gustave…
Jun 28, 2024, 14:22 | Blog
Julia Lai-Kwon: Enjoyed a pre MASCC24 visit to Gustave Roussy
Julia Lai-Kwon, Medical Oncologist and PhD candidate at Peter Mac Cancer Centre, recently shared a…
Jun 28, 2024, 04:59 | Blog
Mihaela Aldea received a 2024 IASLC YIA
Mihaela Aldea, Medical Oncologist at the Gustave Roussy, shared a post on X: "Honored to…
Jun 27, 2024, 14:15 | Blog
David Planchard: Nice post-ASCO24 at Gustave Roussy with the lung session
David Planchard shared on LinkedIn: "Nice post-ASCO24 Gustave Roussy with the lung session. What wonderful…
Jun 21, 2024, 07:47 | Blog
Blood Cancers Today - Is reduced-duration venetoclax in AML effective?
Blood Cancers Today shared a post on X: "Is reduced-duration venetoclax in AML effective?  A study…
Jun 9, 2024, 08:43 | Insight
Daniel Stover: Activity post-breast cancer diagnosis: Is ‘exercise’ just ‘exercise’?
Daniel Stover, Medical Oncologist and Computational Biologist at Ohio State University Comprehensive Cancer Center, shared…
Jun 2, 2024, 12:19 | Blog
Ines Vaz Luis: Such an honor to receive a mentorship award
Ines Vaz Luis, Director of Cancer Survivorship Research Group at Gustave Roussy, shared a post…
May 23, 2024, 14:25 | Insight
Benjamin Besse: Should we infuse IO in the morning?
Benjamin Besse, Head of Clinical Research on Gustave Roussy, shared on X: "Should we infuse…
May 15, 2024, 14:44 | Blog
Maria Babak: Welcome to our May edition of Babak Monthly!
Maria Babak, Head of Drug Discovery Lab at City University of Hong Kong, shared a post…
May 14, 2024, 16:52 | Insight
Fabrice Andre: This risk-based approach is the foundation of modern cancer prevention centers
Fabrice Andre, Head of Research Division at Gustave Roussy, shared on X: "In this review ⁦of…
May 10, 2024, 14:48 | Blog
Rémi Thiolet: Gustave Roussy had the honor to meet the PM of Egypt and Minister of Health and Population
Rémi Thiolet, International advisor and Head of International Affairs at Gustave Roussy, shared on LinkedIn:…
May 5, 2024, 22:37 | Opinion
Vivek Subbiah: A story of meeting with a legend
Vivek Subbiah shared a post on LinkedIn: “Sharing a story of meeting with a legend ……
May 2, 2024, 23:11 | Blog
Vivek Subbiah: My first time inside Gustave Roussey in Paris France
Vivek Subbiah shared a post on LinkedIn: “My first time inside Gustave Roussey in Paris France.…
May 2, 2024, 14:25 | Insight
Fabrice Andre: A nice seminar around Precision Medicine
Vivek Subbiah shared a post by Fabrice Andre, Head of Research Division at Gustave Roussy…
May 1, 2024, 20:07 | Blog
Vivek Subbiah: Looking forward to delivering the keynote at the esteemed PRISM center in Paris
Vivek Subbiah shared a post on LinkedIn: “Just landed in Paris! Looking forward to delivering…
May 1, 2024, 10:06 | Insight
David Planchard: Proud to present 1st results of ICARUS-Lung 01 study
David Planchard, Professor at the University of Paris-Saclay, posted on LinkedIn: “Superb oral session on…
Apr 30, 2024, 14:56 | Blog
Fabrice Andre: ESMO is launching a monthly virtual journal club
Fabrice Andre, Head of Research Division at Gustave Roussy and President-Elect at ESMO, shared on…
Apr 26, 2024, 12:00 | Blog
Vivek Subbiah: Window of opportunity (WOO) studies across cancer subtypes by Barbara Pistilli
Vivek Subbiah shared a post on X/Twitter: "Window of opportunity (WOO) studies across cancer subtypes?…
Apr 26, 2024, 08:52 | Blog
Yuksel Urun: A brilliant perspective and a lesson-laden approach from Bernard Escudier, Gustave Roussy
Yuksel Urun, Professor in Department of Medical Oncology at Ankara University School of Medicine, shared…
Apr 17, 2024, 10:09 | Positive
Yaniss B.: The 3rd edition of the Transatlantic Exchanges in Oncology was a huge success!
Yaniss B, Valorisation Officer at Gustave Roussy Transfert shared on X: “The 3rd edition of the…
Apr 16, 2024, 13:22 | Blog
Toni Choueiri: And that is a wrap for the Transatlantic conference between Dana-Farber, Gustave Roussy
Toni Choueiri shared on their X/Twitter: ''And that is a wrap for the Transatlantic conference…
Apr 16, 2024, 12:58 | Drugs
Emre Yekedüz: A retrospective study from Gustave Roussy
Emre Yekedüz, Associate Professor of Medical Oncology at Ankara University and Research Fellow at Dana-Farber Cancer…
Apr 16, 2024, 02:27 | Blog
Dana-Farber Cancer Institute and Gustave Roussy are proud to share their progress in cancer treatment
Gustave Roussy shared on X/Twitter: "Launch of the Third Transatlantic exchange in Oncology in Boston. Dana-Farber…
Apr 6, 2024, 10:04 | Drugs
Jean Zeghondy: Our work on Tucatinib combination post Trastuzumab-Deruxtecan in HER2+ Metastatic Breast Cancer published in JAMA Network Open
Jean Zeghondy, Associate Practitioner at the Breast Cancer Unit at Gustave Roussy, shared a post…
Feb 27, 2024, 19:03 | Blog
Humaid Al-Shamsi: We had the pleasure to share our experience with Prof. Planchard in treating 10 complex lung cancer cases
Humaid Al-Shamsi, Director of Burjeel Cancer Institute (BCI), posted on LinkedIn: "With Prof. David Planchard…
Feb 22, 2024, 10:58 | Blog
Toni Choueiri: The 3rd transatlantic exchanges between Dana-Farber Cancer Institute and Gustave Roussy happening on April 12
Toni Choueiri, Senior Executive and Chief of Genitourinary Cancers at Dana-Farber Cancer Institute, shared a…
Feb 20, 2024, 15:58 | Blog
Fabrice Barlesi: Gustave Roussy's new building will form part of the largest cancer campus in France
Fabrice Barlesi, Chief Executive Officer at Gustave Roussy, shared on LinkedIn: "To boost its research…
Dec 30, 2023, 04:35 | Insight
Antonin Marchais: A publication full of hope for improving the management of osteosarcoma
Antonin Marchais, Researcher and Leader of the Osteosarcoma Research Group at Gustave Roussy, shared on LinkedIn:…
Nov 28, 2023, 16:24 | Blog
Elsa Bernard: Very happy to join Gustave Roussy to lead a Computational Clinical Oncology group!
Elsa Bernard, a Visiting Research Scientist at The Francis Crick Institute, recently shared on X/Twitter:…
Sep 22, 2023, 18:44 | Blog
Brian Alexander: Excited about our new collaboration with Gustave Roussy and Roche France to bring liquid biopsy genomic testing to patients in France.
Brian Alexander, CEO of Foundation Medicine, shared on LinkedIn: "Excited about our new collaboration with…
Sep 12, 2023, 20:05 | Insight
Benjamin Besse: Time to change our practice and give our IOs in the morning?
Benjamin Besse, Head of Clinical Research at Gustave Roussy, shared on Twitter: "Accumulative publications showing…
Aug 22, 2023, 09:53 | Blog
David Planchard: Amphitheater full, impressive and top organization by the ESMO staff.
Quoting David Planchard, Thoracic Oncologist and Head of Thoracic Cancer Group at Gustave Roussy, stated…
Aug 16, 2023, 18:57 | Insight
Pablo Berlanga Charriel: It is a pleasure to announce that the first results of the SACHA France study have recently been published.
Pablo Berlanga Charriel, Pediatric Oncology Consultant at Gustave Roussy, recently shared on LinkedIn: "It is…
Jul 21, 2023, 18:38 | Positive
A milestone was achieved last week at Gustave Roussy radiotherapy department - Eric Deutsch
A milestone was achieved last week at Gustave Roussy radiotherapy department with the arrival of the…
All: 47 Posts: 1 - 100
Special Coverage